• 1
  • 2
  • 3
  • 4
  • 5

About us

MBM ScienceBridge GmbH evaluates, protects and commercializes inventions of higher education institutions and research facilities. It was founded as a private company and wholly owned subsidiary of the University of Göttingen Public Law Foundation in 2004.

We see our mission in the motivation of scientists to also look at their own research results from the perspective of an economically relevant invention and to report such to the employer as an employee invention.

In the case of promising inventions, we coordinate the application for an intellectual property right with external patent lawyers who are specialised in the relevant field

We subsequently present such inventions worldwide to companies in order to identify partners who are interested in developing the invention into a product and placing the product onto the market

New Genetic Test for Bleeding disorders in Dogs

Genetic tests are playing an increasingly important role in today's dog breeding. They allow breeders to improve targeted mating in order to avoid genetic diseases in offsprings. In the past, intense selection for specific desirable traits and dog types has promoted a large number of genetic defects, which are passed on without any monitoring possibilities. Especially autosomal recessive mutations have been shown to cause essential problems for several dog breeds as genetic carriers cannot be phenotypically detected without any genetic testing.


Bleeding disorders represent a large group of diseases which are often not recognized in time before breeding decisions are made, especially due to the varying onsets of the diseases. The absence of coagulation factor I (fibrinogen) is described as afibrinogenemia. Typical clinical signs are prolonged clotting time, cord or mucosal bleeding, haematomas, haemarthroses or severe bleeding after trauma or surgery. As disorders such as congenital afibrinogenemia can produce severe or fatal bleeding diathesis, there is an urgent need for novel genetic markers that are predictive for such bleeding disorders.

Our Solution

The present invention allows to analyze a genetic defect causing afibrinogenemia in dogs. A particular and novel mutation in the FGA gene is perfectly associated with a severe form of afibrinogenemia. Perfect association has been validated across a large number of dogs from many different breeds. The mutation can be lethal for puppies in a homozygous state. Survival may be possible for short time with intense medical care. Dogs with a heterozygous genotype are healthy carriers but can pass on the mutation to their progeny. This new genetic test can avoid further spreading of this lethal mutation.


  • New genetic test for the lethal bleeding disorder afibrinogenemia.
  • Genetic variant is perfectly associated with a severe and lethal form of afibrinogenemia.
  • Dogs can be tested at any age to identify genetic carriers.
  • Confidence and assurance for dog breeders in their breeding decisions.


Genetic test for bleeding disorders in dogs (diagnostics).

Developmental Status

The genetic test has been successfully tested and validated in Dachshunds including standard, miniature and rabbit size types as well as wire, smooth and long hair types.

Patent Status

A European patent application has been filed (Applicant: University of Veterinary Medicine Hannover, Foundation, Germany).


Dr. Stefan Uhle
Patent Manager Life Science
E-Mail: suhle(at)sciencebridge.de
Tel: +49 551 30724 154
Reference: BioC-2025-Tiho

Tags: Diagnostic

Our Partners


Looking for innovation

MBM ScienceBridge GmbH supports scientists, evaluates inventions, oversees applications for intellectual property rights and out-licenses patents of universities and research institutions in Göttingen and Lower Saxony.

Our company evaluates, protects and commercializes inventions of higher education institutions and research facilities. It was founded as a private company and wholly owned subsidiary of the University of Göttingen, Public Law Foundation, in 2004.

Office of MBM ScienceBridge GmbH:
The office of the MBM ScienceBridge GmbH resides in the Laser Laboratory on the northern campus of the Georg-August-University Göttingen.

A subsidiary of

Georg-August-Universität Göttingen